December 5, 2023 01:22 PM ESTUpdated 05:45 PM

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Resonance Medicine, a two-year-old stealth-stage biotech out of the lab of famed biochemist David Liu, has decided to shut down, Endpoints News has learned. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

Senior Reporter

Senior Biopharma Correspondent

Sign up to read this article for free.

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down